Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Pulmonary Hypertension, March 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 201 articles:
HTML format


 

Single Articles

  1. HAMILTON GW, Fletcher LR, Harley W, Azzopardi R, et al
    Differences in Direct Fick and Thermodilution Measurements of Cardiac Output: Impact on Pulmonary Hypertension Classification.
    Pulm Circ. 2025;15:e70053.
    PubMed    
    Abstract available

  2. SANT K, Johnson J, Suepaul R, Corradini I, et al
    Cor Pulmonale and Secondary Pulmonary Arteriolar Hypertension in a Red Howler (Alouatta seniculus) Associated With Klebsiella pneumoniae Pneumonia.
    J Med Primatol. 2025;54:e70010.
    PubMed    
    Abstract available

  3. KERBER B, Hullner M, Maurer A, Flohr T, et al
    Photon-Counting Detector CT Iodine Maps Versus SPECT/CT: Advancing Lung Perfusion Imaging in Chronic Thromboembolic Pulmonary Hypertension.
    Invest Radiol. 2025 Feb 28. doi: 10.1097/RLI.0000000000001163.
    PubMed    
    Abstract available

  4. CRAMER-BOUR C, Prakash P, Venkat D, Afonso L, et al
    An Interdisciplinary Pulmonary Hypertension Curriculum for Fellows.
    ATS Sch. 2025 Feb 27. doi: 10.34197/ats-scholar.2024-0089.
    PubMed    


  5. HEKIMSOY V, Kaya EB
    Assessment of the prevalence of hypotension in precapillary pulmonary hypertension patients with preserved right ventricle function.
    Blood Press Monit. 2025 Feb 24. doi: 10.1097/MBP.0000000000000747.
    PubMed    
    Abstract available

  6. CASTELLI R, Atzori E, Delitala AP, Masala SA, et al
    Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature.
    Front Cardiovasc Med. 2025;12:1508574.
    PubMed    
    Abstract available

  7. TAKEYAMA S, Hanaoka H, Hashimoto A, Ishii Y, et al
    A cohort study in HigAshi-nippon of Pulmonary hyPertensIoN in systEmic SclerosiS (HAPPINESS study): protocol and baseline data for an observational study.
    BMC Rheumatol. 2025;9:25.
    PubMed    
    Abstract available

  8. TU TH, Lu JW, Wu CH, Ho YJ, et al
    Molecular Hydrogen Therapy for SLE-PAH: Case Report on Immune Marker Modulation.
    In Vivo. 2025;39:1211-1219.
    PubMed    
    Abstract available

  9. NEELAKANTAN S, Vang A, Mehdi RR, Phelan H, et al
    Right Ventricular Stiffening and Anisotropy Alterations in Pulmonary Hypertension: Mechanisms and Relations to Right Heart Failure.
    J Am Heart Assoc. 2025 Feb 26:e037126. doi: 10.1161/JAHA.124.037126.
    PubMed    
    Abstract available

  10. ZHANG C, Su X, Zhang Y, He P, et al
    Triangular Causality Among Pulmonary Hypertension, Sleep Disorders, and Brain Structure at the Genetic Level: A Mendelian Randomization Study Focused on the Lung-Brain Axis.
    Nat Sci Sleep. 2025;17:343-356.
    PubMed    
    Abstract available

  11. YOGESWARAN A, Funderich M, Olschewski H, Kovacs G, et al
    Association of pulmonary hypertension-targeted therapy and survival in precapillary pulmonary hypertension with mean pulmonary arterial pressure between 21 and 24 mmHg.
    ERJ Open Res. 2025;11:00466-2024.
    PubMed    
    Abstract available

  12. KRISHNA SVS, Rana S, Singh P, Choudhary R, et al
    A Study on Prevalence of Asymptomatic Pulmonary Hypertension in Patients of Metabolic Syndrome with Obstructive Sleep Apnea.
    Ann Afr Med. 2025 Feb 25. doi: 10.4103.
    PubMed    
    Abstract available

  13. KURNIK M, Bozic H, Podbregar M
    Systolic Pulmonary Artery Pressure as Long-Term Mortality Predictor in Elderly Critically Ill with Severe COVID-19 Pneumonia.
    Viruses. 2025;17:244.
    PubMed    
    Abstract available

  14. LYHNE MD, Yuriditsky E, Zochios V, Dragsbaek SJ, et al
    Pulmonary Artery Pulsatility Index in Acute and Chronic Pulmonary Embolism.
    Medicina (Kaunas). 2025;61:363.
    PubMed    
    Abstract available

  15. MORIMATSU Y, Tahara N, Okamoto M, Bekki M, et al
    Sarcoidosis-Associated Pulmonary Hypertension.
    Medicina (Kaunas). 2025;61:342.
    PubMed    
    Abstract available

  16. HIDA Y, Imamura T, Ushijima R, Kinugawa K, et al
    Efficacy of Inhaled Treprostinil in a Patient with Systemic Sclerosis-Associated Pulmonary Hypertension and Interstitial Lung Diseases Refractory to Conventional Intravenous Epoprostenol.
    Medicina (Kaunas). 2025;61:184.
    PubMed    
    Abstract available

  17. BARNIKEL M, Kneidinger N, Gerckens M, Mummler C, et al
    Current Blood Eosinophilia Does Not Predict the Presence of Pulmonary Hypertension in Patients with End-Stage Lung Disease.
    J Clin Med. 2025;14:1120.
    PubMed    
    Abstract available

  18. ENEA I, Vedovati MC, Scelsi L, Garascia A, et al
    [Clinical-instrumental management and anticoagulant therapy in the follow-up of patients with pulmonary embolism: the results of the "FOLLOW-EP" survey promoted by the ANMCO Working Group on Pulmonary Vascular Diseases].
    G Ital Cardiol (Rome). 2025;26:195-204.
    PubMed    
    Abstract available

  19. MULLEN E, McCullagh B, Gaine S, Quadery SR, et al
    Recent Advances in the Diagnosis and Management of Pulmonary Arterial Hypertension.
    Br J Hosp Med (Lond). 2025;86:1-13.
    PubMed    
    Abstract available

  20. KAKIZAKI R, Raber L, Gerges C, Dorfmuller P, et al
    3D Reconstruction of Pulmonary Vascular Lesions in Chronic Thromboembolic Pulmonary Hypertension.
    Circ Cardiovasc Imaging. 2025 Feb 25:e017935.
    PubMed    


  21. SKAARA H
    My journey with pulmonary hypertension: From diagnosis to thriving.
    Int J Cardiol Congenit Heart Dis. 2025;19:100572.
    PubMed    


  22. YOUNIS A, Reddy YNV, Miranda WR, Abdelhalim AT, et al
    Temporal changes in prevalence and severity of pulmonary hypertension, and relationship to outcomes in coarctation of aorta.
    Int J Cardiol Heart Vasc. 2025;57:101626.
    PubMed    
    Abstract available

  23. XU W, Xi L, Ni Y, Wang J, et al
    Artificial intelligence-driven quantitative analysis of CT morphological differences between chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease.
    Quant Imaging Med Surg. 2025;15:1101-1113.
    PubMed    
    Abstract available

  24. LAURIA MJ, Merelman A, Thompson JL, Braude DA, et al
    Management of Critically Ill Patients With Pulmonary Arterial Hypertension in Transport: A Narrative Review.
    Air Med J. 2025;44:73-82.
    PubMed    
    Abstract available

  25. KURIMURA T, Omura T, Yamamoto K, Tanaka H, et al
    Prolonged Prothrombin Time due to Drug-Drug Interaction of Warfarin after the Change from Bosentan to Macitentan: A Case of Pharmacist Intervention in the Outpatient Clinic.
    Kobe J Med Sci. 2025;70:E125-E129.
    PubMed    
    Abstract available

  26. LIAO Y, Wu B
    Analysis of clinical features and risk factors of pulmonary hypertension associated with interstitial lung disease.
    Biomed Rep. 2025;22:58.
    PubMed    
    Abstract available

  27. SIVAKUMAR N, Zhang C, Chang-Chien C, Gu P, et al
    An Unsupervised Approach to Derive Right Ventricular Pressure-Volume Loop Phenotypes in Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70057.
    PubMed    
    Abstract available

  28. LLUCIA-VALLDEPERAS A, van Wezenbeek J, Groeneveldt JA, Smal R, et al
    Bone morphogenetic protein 10 is increased in precapillary pulmonary hypertension patients.
    Cardiovasc Res. 2025 Feb 24:cvaf028. doi: 10.1093.
    PubMed    
    Abstract available

  29. BRIONES-CLAUDETT KH, Briones-Zamora KH, Benites Solis JG, Huilcapi Borja DI, et al
    Severe COVID-19 Pneumonia, Opportunistic Candida krusei Infection, and Acute Respiratory Distress Syndrome with Pulmonary Arterial Hypertension Treated with Bosentan: A Case Report.
    Am J Case Rep. 2025;26:e946400.
    PubMed    
    Abstract available

  30. BURYSKOVA SALAJOVA K, Malik J, Kaiserova L, Hladinova Z, et al
    Right ventricular-pulmonary arterial coupling and pulmonary hypertension in hemodialysis: insights into structural cardiac changes and clinical implications.
    Ren Fail. 2025;47:2466822.
    PubMed    
    Abstract available

  31. LI M, Chen D, Fan J, Tian D, et al
    The efficacy, safety and clinical feasibility of a percutaneous atrial septal shunt device for pulmonary arterial hypertension: a single-center cohort study.
    Respir Res. 2025;26:67.
    PubMed    
    Abstract available

  32. SHANAHATI D, Yang T, Fang L, Nijiati Y, et al
    18beta-Glycyrrhetinic acid improves pulmonary hypertension by regulating the vascukar non-inflammatory molecule-1/L-arginine/nitric oxide signaling pathway.
    Eur J Pharmacol. 2025 Feb 21:177382. doi: 10.1016/j.ejphar.2025.177382.
    PubMed    
    Abstract available

  33. CHOUGULA PV, Suryawanshi P, Bharadwaj R, Malshe N, et al
    Alveolar capillary dysplasia in a neonate: emphasising the importance of early recognition and biopsy in refractory pulmonary hypertension.
    BMJ Case Rep. 2025;18:e264699.
    PubMed    
    Abstract available

  34. DENG X, Que Q, Zhang K, Li B, et al
    Mechanistic insights into the role of EGLN3 in pulmonary vascular remodeling and endothelial dysfunction.
    Respir Res. 2025;26:61.
    PubMed    
    Abstract available

  35. ALBENDEA-GOMEZ T, Mendoza-Tamajon S, Castro-Mecinas R, Escobar B, et al
    Vascular HIF2 Signaling Prevents Cardiomegaly, Alveolar Congestion, and Capillary Remodeling During Chronic Hypoxia.
    Arterioscler Thromb Vasc Biol. 2025;45:e78-e98.
    PubMed    
    Abstract available

  36. RAMIREZ DA, Anninger WV, Scoles D
    OPTIC NERVE HYPOPLASIA AND BILATERAL PERSISTENT FETAL VASCULATURE DUE TO TUBA1A TUBULINOPATHY.
    Retin Cases Brief Rep. 2025;19:264-266.
    PubMed    
    Abstract available

  37. WANG D, Singh H, Miller A, VonTungeln CD, et al
    Hypereosinophilic Syndrome in a Patient With Complex Pulmonary Hypertension and Sjogren's Syndrome: A Case Report.
    Cureus. 2025;17:e78486.
    PubMed    
    Abstract available

  38. YAN X, Song Y, Zhang H, Guo T, et al
    Improvement in oxygen dynamics after 3 months of home-based respiratory muscle rehabilitation in a patient with complex severe pulmonary hypertension: A case report.
    Chronic Dis Transl Med. 2024;11:78-80.
    PubMed    


  39. DEVESA A, Robson PM, Cangut B, Pyzik R, et al
    Can pulmonary artery (18)F-FDG uptake serve as a risk marker in precapillary pulmonary hypertension?
    Eur J Nucl Med Mol Imaging. 2025 Mar 7. doi: 10.1007/s00259-025-07181.
    PubMed    


  40. GUO WJ, Liu DT, Xiao Y, Man TT, et al
    [Methamphetamine-associated pulmonary arterial hypertension: a case report].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:261-266.
    PubMed    
    Abstract available

  41. JIANG Q, Yan H, Huang C, Ma R, et al
    [An analysis of clinical and genetic feature in pulmonary artery sarcoma].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:256-260.
    PubMed    
    Abstract available

  42. ZHAO Y, Ding C, Su H, Wang A, et al
    Single Test-Based Diagnosis and Subtyping of Pulmonary Hypertension Caused by Fibrosing Mediastinitis Using Plasma Metabolic Analysis.
    Adv Sci (Weinh). 2025 Mar 6:e2416454. doi: 10.1002/advs.202416454.
    PubMed    
    Abstract available

  43. MUKHERJEE M, Rudski LG, Addetia K, Afilalo J, et al
    Guidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension: Recommendations from the American Society of Echocardiography.
    J Am Soc Echocardiogr. 2025;38:141-186.
    PubMed    
    Abstract available

  44. TURA-CEIDE O, Oto J, Osorio J, Hervas D, et al
    The Potential of Extracellular Microvesicle-microRNAs in Precapillary Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2025 Mar 5. doi: 10.1165/rcmb.2024-0282.
    PubMed    


  45. HU L, Chen F
    A Novel Role for Platelet-Endothelial Crosstalk in Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2025 Mar 5. doi: 10.1165/rcmb.2025-0044.
    PubMed    


  46. SHEN Y
    Will Stub1 Be the Next Target for Pulmonary Hypertension Therapy Development?
    Am J Respir Cell Mol Biol. 2025 Mar 5. doi: 10.1165/rcmb.2025-0034.
    PubMed    


  47. ZOULIKHA M, Zou J, Yang P, Wu J, et al
    Cocrystal pleomorphism-inspired drug nanoassembly for pulmonary-endothelium targeting and pulmonary hypertension treatment.
    Acta Pharm Sin B. 2025;15:557-570.
    PubMed    
    Abstract available

  48. VARON-VEGA F, J Tellez L, Tuta-Quintero E, Rincon A, et al
    Impact of Pulmonary Hypertension on Posttransplant Survival of Patients With Pulmonary Fibrosis at High Altitude: A Prospective Cohort Study.
    Can Respir J. 2025;2025:1861990.
    PubMed    
    Abstract available

  49. BATTILANA B, Chiffi K, Lichtblau M, Mayer L, et al
    Impact of the establishment of a multidisciplinary national chronic thromboembolic pulmonary hypertension board on a monocentric surgical endarterectomy program.
    Interdiscip Cardiovasc Thorac Surg. 2025.
    PubMed    
    Abstract available

  50. CHEN BX, Hu H, Gong J, Xi XY, et al
    Comparison of the value of FAPI imaging and speckle?tracking echocardiography in assessment of right ventricular remodeling in pulmonary hypertension.
    BMC Med Imaging. 2025;25:68.
    PubMed    
    Abstract available

  51. TOLDI G
    Leveraging oxygen saturation monitoring for improved detection of pulmonary hypertension in preterm infants.
    Pediatr Res. 2025 Mar 3. doi: 10.1038/s41390-025-03974.
    PubMed    


  52. ABOUZID MR, Kamel I, Twayana AR, Shrestha S, et al
    Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis.
    Int J Cardiol. 2025 Mar 1:133078. doi: 10.1016/j.ijcard.2025.133078.
    PubMed    
    Abstract available

  53. KITAOKA H, Kobayashi R, Tanaka K, Watanabe M, et al
    Inhaled nitric oxide for bronchopulmonary dysplasia-associated pulmonary hypertension: A systematic review and narrative synthesis.
    Neonatology. 2025 Mar 3:1-22. doi: 10.1159/000545034.
    PubMed    
    Abstract available

  54. MARINHO JT, Marafon BB
    The pathological blood flow steal phenomenon limits exercise tolerance in pulmonary hypertensive rats.
    J Physiol. 2025 Mar 3. doi: 10.1113/JP288421.
    PubMed    


  55. TSUTSUI M, Yatera K
    Significance of nitric oxide derived from the nitric oxide synthases system in cardiovascular interorgan crosstalk.
    J Pharmacol Exp Ther. 2025;392:100025.
    PubMed    
    Abstract available

  56. WU J, Huang Q, Zhang Y, De Z, et al
    Impact of BMPR2 mutation on the severity of pulmonary arterial hypertension: a systematic review and meta-analysis.
    Respir Res. 2025;26:74.
    PubMed    
    Abstract available

  57. CZERWINSKI A, Sidlowski P, Mooers E, Liu Y, et al
    Stub1 Acetylation by CBP/p300 Attenuates Chronic Hypoxic-driven Pulmonary Hypertension by Suppressing HIF-2alpha.
    Am J Respir Cell Mol Biol. 2025 Feb 28. doi: 10.1165/rcmb.2024-0353.
    PubMed    
    Abstract available

  58. CHEN L, Bai Q, Tang R, Cen C, et al
    GP IIb/IIIa-ICAM-1 Mediated Platelet-Endothelial Adhesion Exacerbates Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2025 Feb 28. doi: 10.1165/rcmb.2024-0438.
    PubMed    
    Abstract available

  59. FENG J, Liu Y, Li K, Wu Y, et al
    Challenges and opportunities in targeting epigenetic mechanisms for pulmonary arterial hypertension treatment.
    Int J Pharm. 2025;672:125332.
    PubMed    
    Abstract available

  60. SHUSHANYAN RA, Karapetyan HM, Nadiryan EE, Avtandilyan NV, et al
    Tissue remodeling during high-altitude pulmonary edema in rats: Biochemical and histomorphological analysis.
    Tissue Cell. 2025;93:102727.
    PubMed    
    Abstract available

  61. BENJAMIN N, Schiffer V, Resag C, Xanthouli P, et al
    Sex-Specific Differences in Echocardiographic Parameters of Risk Stratification in Pulmonary Arterial Hypertension.
    J Am Soc Echocardiogr. 2025;38:273-285.
    PubMed    
    Abstract available

  62. YAGI S, Kadota M, Bando R, Miyamoto R, et al
    Pulmonary Arterial Hypertension in Neurofibromatosis Type 1: A Case with a Novel NF1 Gene Mutation.
    Intern Med. 2025;64:725-728.
    PubMed    
    Abstract available

  63. HUANG S, Li N, Yan D
    Delayed treatment with endostatin displays a protective role against pulmonary hypertension by targeting VEGF pathway.
    Minerva Med. 2025;116:13-21.
    PubMed    
    Abstract available

  64. HU B, Zhong H, Shi R, Chen Z, et al
    A study on the genetic comorbidity between autoimmune diseases and pulmonary hypertension: an observational study and POST-GWAS analysis.
    Int J Med Sci. 2025;22:1344-1362.
    PubMed    
    Abstract available

  65. RAUF R, Gibson CA, Alahmad MAM
    Impact of Frailty on Inpatient Mortality and Resource Utilization for Primary Pulmonary Hypertension.
    Avicenna J Med. 2025;14:204-209.
    PubMed    
    Abstract available

  66. LU Y, Yang Y, Fu Y, Xiong C, et al
    Global research trends on chronic thromboembolic pulmonary hypertension: a bibliometric analysis (January 2000-January 2024).
    J Thorac Dis. 2025;17:724-743.
    PubMed    
    Abstract available

  67. TORUN EG, Bagrul D, Ece I
    Recanalization and interventional stenting of a closed ductus arteriosus in pulmonary hypertension associated with von Hippel-Lindau disease: a case report.
    Cardiol Young. 2025 Mar 14:1-4. doi: 10.1017/S1047951125001374.
    PubMed    
    Abstract available

  68. CARDILLO C, Criner GJ, Gayen S
    Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study.
    Ther Adv Respir Dis. 2025;19:17534666251326743.
    PubMed    
    Abstract available

  69. TANG Z, Yang F, Wu H, Zhao Y, et al
    Alterations in nailfold videocapillaroscopy among patients with connective tissue diseases combined with pulmonary arterial hypertension: A cross-sectional study.
    Sci Rep. 2025;15:8647.
    PubMed    
    Abstract available

  70. PENG TY, Lu JM, Zheng XL, Zeng C, et al
    The role of lactate metabolism and lactylation in pulmonary arterial hypertension.
    Respir Res. 2025;26:99.
    PubMed    
    Abstract available

  71. WEI Y, Wu H, Guo J, Sun X, et al
    A patient with Eradheim-Chester disease presenting with progressive cystic lung lesions and confirmed pulmonary artery hypertension: a case report.
    BMC Pulm Med. 2025;25:110.
    PubMed    
    Abstract available

  72. RODRIGUEZ JV, Zhang H, Mesfin N, Klings ES, et al
    Contribution of QRS Prolongation to Transplant-Free Survival in Sarcoidosis-Related Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70021.
    PubMed    
    Abstract available

  73. MEKOV EV, Yanev NA, Kurtelova N, Mihalova T, et al
    Prevalence and Prognostic Value of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.
    Cureus. 2025;17:e78769.
    PubMed    
    Abstract available

  74. LEY L, Wiedenroth CB, Guth S, Gold C, et al
    A simple electrocardiographic model for an improved detection of chronic thromboembolic pulmonary hypertension after pulmonary embolism.
    J Electrocardiol. 2025;90:153908.
    PubMed    
    Abstract available

  75. LIAN H, Chen R, Zeng Y, Guo R, et al
    Exploring the causal relationship between PAH and some autoimmune diseases using bidirectional Mendelian randomization analyses.
    Medicine (Baltimore). 2025;104:e41737.
    PubMed    
    Abstract available

  76. CONTE L, Amodeo I, De Nunzio G, Raffaeli G, et al
    A machine learning approach to predict mortality and neonatal persistent pulmonary hypertension in newborns with congenital diaphragmatic hernia. A retrospective observational cohort study.
    Eur J Pediatr. 2025;184:238.
    PubMed    
    Abstract available

  77. ADU-AMANKWAAH J, You Q, Liu X, Jiang J, et al
    Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.
    MedComm (2020). 2025;6:e70134.
    PubMed    
    Abstract available

  78. ASANO R, Nagase S, Aoki T, Ueda J, et al
    Pulmonary Artery Denervation for Medication Refractory Pulmonary Hypertension (PARPH Study)?- Study Protocol for a Prospective, Open-Label, Single-Arm Clinical Trial.
    Circ Rep. 2025;7:212-215.
    PubMed    
    Abstract available

  79. JIANG W, Wu Z, Huang C, Lu T, et al
    Reverse Potts shunt in severe pulmonary hypertension: A 20-year retrospective review.
    Int J Cardiol. 2025;428:133129.
    PubMed    
    Abstract available

  80. IBARRA-RIOS D, Mantilla-Uresti JG, Barrios-Bautista DM, Penarrieta-Daher A, et al
    Hemodynamic phenotypes in congenital diaphragmatic hernia and their association with morbidity and mortality.
    Bol Med Hosp Infant Mex. 2025;82:54-62.
    PubMed    
    Abstract available

  81. YANG X, Liu H, Wu X
    High-altitude pulmonary hypertension: a comprehensive review of mechanisms and management.
    Clin Exp Med. 2025;25:79.
    PubMed    
    Abstract available

  82. MA W, Ma Y, Bai Y, Su X, et al
    Changes in Macrophages in Pulmonary Hypertension: A Focus on High-altitude Pulmonary Hypertension.
    Anatol J Cardiol. 2025 Mar 10. doi: 10.14744/AnatolJCardiol.2025.5013.
    PubMed    
    Abstract available

  83. LACERDA TEIXEIRA B, Grazina A, Morais LA, Galrinho A, et al
    Pulmonary Hypertension and Acute Heart Failure Following Lumbar Disc Surgery.
    J Soc Cardiovasc Angiogr Interv. 2024;4:102453.
    PubMed    
    Abstract available

  84. ZHANG C, Zhong B, Jiang Q, Lu W, et al
    Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups.
    BMC Med. 2025;23:148.
    PubMed    
    Abstract available

  85. SUGIYAMA Y, Tahara N, Honda A, Koga Y, et al
    Utility of liver stiffness for the classification of portopulmonary hypertension in precapillary pulmonary hypertension.
    Int J Cardiol. 2025 Mar 7:133126. doi: 10.1016/j.ijcard.2025.133126.
    PubMed    
    Abstract available

  86. COPPI F, Cavalletti A, Pagnoni G, Campani C, et al
    Pulmonary hypertension in patients with Sjogren's syndrome: Gender differences in cardiovascular risk factors and instrumental data.
    Int J Cardiol. 2025;428:133131.
    PubMed    
    Abstract available

  87. PAEZ-CARPIO A, Zarco FX, Serrano E, Vollmer I, et al
    Cone beam CT pulmonary angiography in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension during the program initiation period.
    Clin Radiol. 2025;84:106847.
    PubMed    
    Abstract available

  88. TAKANO R, Fujisaki S, Endo H, Nishi N, et al
    The clinical impact of acute vasoreactivity testing in patients with severe pulmonary hypertension associated with lung disease: A retrospective exploratory analysis.
    Respir Investig. 2025;63:326-333.
    PubMed    
    Abstract available

  89. AKBARI A, Raji H, Islampanah M, Barati S, et al
    Sleep apnea in pulmonary hypertension patients: a systematic review and meta-analysis sleep disorders and pulmonary hypertension.
    Sleep Breath. 2025;29:120.
    PubMed    
    Abstract available

  90. BLANCO I, Kovacs G
    Diagnostic and Therapeutic Innovations in Pulmonary Hypertension: News From the 2024 World Symposium on Pulmonary Hypertension.
    Arch Bronconeumol. 2025 Feb 21:S0300-2896(25)00064.
    PubMed    


  91. ALI HJ, Cui S, Sahay S, Grosu HB, et al
    Pulmonary Tumor Thrombotic Microangiopathy: A Rapidly Progressive Form of Pulmonary Hypertension in Cancer Patients.
    JACC Case Rep. 2025;30:103194.
    PubMed    
    Abstract available

  92. ROBINSON E, Logan C, Chiu S, Husain N, et al
    Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension Secondary to Expanded Polytetrafluoroethylene Valved Pulmonary Conduit Thrombosis.
    JACC Case Rep. 2025;30:103069.
    PubMed    
    Abstract available

  93. GUPTA A, Zaghloul N, Thulasingam SK, Robbins IR, et al
    Tailored CD4+ lymphocytes expressing human CHAT protein as a novel vasodilator in attenuating RV pressure in PAH animal model.
    Transl Res. 2025;278:22-35.
    PubMed    
    Abstract available

  94. LI HS, Liu HJ, Zhang Y, Zhang J, et al
    Chronic intermittent hypobaric hypoxia prevents pulmonary arterial hypertension through maintaining eNOS homeostasis.
    Arch Biochem Biophys. 2025;767:110340.
    PubMed    
    Abstract available

  95. ZENG Z, Wang X, Wang H, Tian L, et al
    Role of Xuefu Zhuyu decoction in improving pulmonary vascular remodeling by inhibiting endothelial-to-mesenchymal transition.
    Vascul Pharmacol. 2025;158:107467.
    PubMed    
    Abstract available

  96. VERSTRAETEN M, Lefere S, Raevens S
    Pulmonary vascular complications of cirrhosis: hepatopulmonary syndrome and portopulmonary hypertension.
    Acta Clin Belg. 2024;79:384-391.
    PubMed    
    Abstract available

  97. BERNARDI N, Neep BF, Garibaldi S, Bianconi E, et al
    The lncRNA DSCR9 is modulated in pulmonary arterial hypertension endothelial cell models and is associated with alterations in the nitric oxide pathway.
    Vascul Pharmacol. 2025;158:107464.
    PubMed    
    Abstract available

  98. ALEXANDER L, Burnie S, Rossiter C, Isles C, et al
    Do low-risk patients really need follow-up after a pulmonary embolism?
    J R Coll Physicians Edinb. 2025;55:14-18.
    PubMed    
    Abstract available

  99. FARHA S, Asosingh K, Hassoun PM, Barnard J, et al
    Alterations in Mitochondrial Function in Pulmonary Vascular Diseases.
    Antioxid Redox Signal. 2025;42.
    PubMed    
    Abstract available

  100. LI J, Villar-Calle P, Chiu C, Reza M, et al
    Spiral cardiac quantitative susceptibility mapping for differential cardiac chamber oxygenation-Initial validation in relation to invasive blood sampling.
    Magn Reson Med. 2025;93:2029-2039.
    PubMed    
    Abstract available

  101. MISEROCCHI G
    Physiopathology of High-Altitude Pulmonary Edema.
    High Alt Med Biol. 2025;26:1-12.
    PubMed    
    Abstract available

  102. GROSSMAN M, Walker S, Ramsey EZ
    Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension.
    Pediatr Cardiol. 2025;46:902-907.
    PubMed    
    Abstract available

  103. ONG JYS, Yap JJY, Dashraath P, Low TT, et al
    Pulmonary hypertension in pregnancy: two sides to a coin.
    Singapore Med J. 2025;66:167-171.
    PubMed    


  104. ONG JYS, Yap JJY, Choolani M, Poh KK, et al
    Cardiovascular-obstetric state-of-the-art review: pulmonary hypertension in pregnancy.
    Singapore Med J. 2025;66:130-140.
    PubMed    
    Abstract available

  105. SELVAN KC, Teerapuncharoen K, Bag R
    Oral Pulmonary Arterial Hypertension-Targeted Therapy in Patients With Pulmonary Hypertension due to Interstitial Lung Disease.
    J Clin Med Res. 2025;17:153-163.
    PubMed    
    Abstract available

  106. STRANGE GA, Maron BA, Zeder K, Chan YK, et al
    Global distribution of prognostically significant pulmonary pressure indicative of pulmonary hypertension.
    J Glob Health. 2025;15:04098.
    PubMed    
    Abstract available

  107. HOSOKAWA K, Abe K
    Milestones in therapeutic and antithrombotic strategies for chronic thromboembolic pulmonary hypertension.
    J Cardiol. 2025 Mar 18:S0914-5087(25)00081-4. doi: 10.1016/j.jjcc.2025.
    PubMed    
    Abstract available

  108. HE J, Liao JH
    Potential Role of Hesperidin in Improving Experimental Pulmonary Arterial Hypertension in Rats via Modulation of the NF-kappaB Pathway.
    Chem Biol Drug Des. 2025;105:e70068.
    PubMed    
    Abstract available

  109. KISHIKAWA R, Kodera S, Setoguchi N, Tanabe K, et al
    An ensemble learning model for detection of pulmonary hypertension using electrocardiogram, chest X-ray, and brain natriuretic peptide.
    Eur Heart J Digit Health. 2025;6:209-217.
    PubMed    
    Abstract available

  110. EL KOOFY N, Okasha SH, Agha HM, Ali N, et al
    Prevalence and Predictors of Pulmonary Hypertension in Children with Portal Hypertension: A Single Center Study.
    Pediatr Gastroenterol Hepatol Nutr. 2025;28:101-112.
    PubMed    
    Abstract available

  111. KINOSHITA M, Tasaka T, Fujimoto K, Saito M, et al
    Impaired Left Atrial Reservoir Strain Causes Exercise-Induced Pulmonary Hypertension in Patients With Preserved Left Ventricular Ejection Fraction.
    Echocardiography. 2025;42:e70139.
    PubMed    
    Abstract available

  112. WU X, Suo S, Su X, Sun L, et al
    Trends in pulmonary arterial hypertension: insights from Global Burden of Disease 1990-2021.
    BMJ Open. 2025;15:e095348.
    PubMed    
    Abstract available

  113. MALDONADO-VELEZ G, Mickler EA, Cook TG, Aldred MA, et al
    Loss of Tbx4 Affects Postnatal Lung Development and Predisposes to Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2025 Mar 19. doi: 10.1165/rcmb.2024-0459.
    PubMed    
    Abstract available

  114. STEPPAN J, Berkowitz DE
    Channeling Hope in the Expanding Landscape of Therapy for Pulmonary Hypertension: Potential Role for Piezo2.
    Hypertension. 2025;82:598-600.
    PubMed    


  115. KRIEGEL ER, Srinivasan A, Mammen L, Venkataganesh H, et al
    Airway Anomalies Predict Risk of Pediatric Pulmonary Hypertension.
    Pediatr Pulmonol. 2025;60:e71028.
    PubMed    
    Abstract available

  116. CULLIVAN S, Genecand L, El-Merhie N, MacKenzie A, et al
    Inhaled treprostinil in group 3 pulmonary hypertension associated with lung disease: results of the INCREASE and PERFECT studies.
    Breathe (Sheff). 2025;21:240242.
    PubMed    
    Abstract available

  117. LEON-ROMAN F, Pintado-Cort B, Barbera JA, Sellares J, et al
    [Diagnosis and Treatment of Pulmonary Embolism and Pulmonary Hypertension in Patients With Interstitial Lung Disease].
    Open Respir Arch. 2025;7:100406.
    PubMed    
    Abstract available

  118. MARTIN DE MIGUEL I, Cruz Utrilla A, Segura de La Cal T, Sarnago Cebada F, et al
    Haemodynamic spectrum in heritable pulmonary arterial hypertension: a continuum from pre-capillary to combined pulmonary hypertension-case series.
    Eur Heart J Case Rep. 2025;9:ytaf109.
    PubMed    
    Abstract available

  119. LI Y, Qian J, Deng X, Ma L, et al
    Deciphering the transcriptomic landscape of systemic lupus erythematosus-associated pulmonary arterial hypertension.
    Respir Res. 2025;26:106.
    PubMed    
    Abstract available

  120. MOLLA FA, Ayalew DG, Astatk HA, Teshager AW, et al
    Prevalence and determinants of pulmonary hypertension in rheumatic heart disease patients at university of Gondar comprehensive specialized hospital: a retrospective study from 2018 to 2023.
    BMC Cardiovasc Disord. 2025;25:193.
    PubMed    
    Abstract available

  121. WANG Z, Li L, Lyu Y, Guo Y, et al
    Correlation between T-lymphocyte subsets and hemodynamics in patients with congenital heart disease-associated pulmonary arterial hypertension.
    Medicine (Baltimore). 2025;104:e41834.
    PubMed    
    Abstract available

  122. MARKIEWITZ ND, Wang Y, Berg RA, Yehya N, et al
    Right Atrial Dysfunction Is Prevalent in Pediatric Acute Respiratory Distress Syndrome and Reflects Pulmonary Hypertension and Right Ventricular Dysfunction.
    Crit Care Explor. 2025;7:e1230.
    PubMed    
    Abstract available

  123. MURAKAMI N, Asano D, Tokushige N, Omura J, et al
    Diagnostic Delays and Quality of Life in Japanese Patients with Pulmonary Hypertension: A Nationwide Survey.
    Pulm Ther. 2025 Mar 18. doi: 10.1007/s41030-025-00290.
    PubMed    
    Abstract available

  124. CHU Z, Li Y, Ge J
    Identification of nitric oxide-related key genes in pulmonary hypertension via bioinformatics and in vitro validation for therapeutic target discovery.
    Comput Methods Biomech Biomed Engin. 2025.
    PubMed    
    Abstract available

  125. NAGATA Y, Nagaoka T, Terayama Y, Suzuki Y, et al
    The Potential of Pulmonary Vasodilators as a Bridging Therapy for Lung Transplantation: Two Cases of Interstitial Pneumonia With Pulmonary Hypertension During the Waiting Period for Lung Transplantation.
    Respirol Case Rep. 2025;13:e70136.
    PubMed    
    Abstract available

  126. CHANG SA, Yang JH, Jung DS, Kim NH, et al
    Recent Advances in Chronic Thromboembolic Pulmonary Hypertension: Expanding the Disease Concept and Treatment Options.
    Korean Circ J. 2025 Feb 10. doi: 10.4070/kcj.2024.0423.
    PubMed    
    Abstract available

  127. KIM BJ, Thomas JD
    Echocardiographic Parameters of the Right Ventricle in Patients With Pulmonary Hypertension: A Review.
    Korean Circ J. 2025 Jan 31. doi: 10.4070/kcj.2024.0313.
    PubMed    
    Abstract available

  128. FRAGER MR, Frishman WH, Aronow WS
    Advances in Atrial Septal Defect Closure: Managing Pulmonary Hypertension and Expanding Treatment Criteria Applicability.
    Cardiol Rev. 2025 Mar 17. doi: 10.1097/CRD.0000000000000896.
    PubMed    
    Abstract available

  129. KRISHNAN S, Adigopula S, Gadeela N
    Delayed Diagnosis of Partial Anomalous Pulmonary Venous Return in an Adult With Pulmonary Hypertension.
    J Investig Med High Impact Case Rep. 2025;13:23247096251326474.
    PubMed    
    Abstract available

  130. PATEL R, Pescatore J, Gayen S
    The FEV1/DLCO Ratio as an Effective Predictor of Severity and Survival in COPD-Associated Pulmonary Hypertension: A Retrospective Analysis.
    J Clin Med. 2025;14:1606.
    PubMed    
    Abstract available

  131. HORVAT D, Orzan RI, Agoston-Coldea L
    A Non-Invasive Approach to Pulmonary Hypertension.
    J Clin Med. 2025;14:1473.
    PubMed    
    Abstract available

  132. MACKINTOSH C, Dreixler J, Tung A, Mueller A, et al
    Plasma Levels of Activin A and Follistatin-Like-3 as Biomarkers for Pulmonary Hypertension in Advanced Heart Failure.
    medRxiv [Preprint]. 2025 Mar 7:2025.03.06.25323530.
    PubMed    
    Abstract available

  133. SPIEKERKOETTER E
    Macrophages: key conductors behind perivascular inflammation and vascular remodeling in hypoxia-induced pulmonary hypertension.
    J Clin Invest. 2025;135:e190957.
    PubMed    
    Abstract available

  134. MIHASHI Y, Miki K, Yanagi H, Maekura T, et al
    Exercise-induced Right-to-left Shunt in a Patient with Combined Pulmonary Fibrosis and Emphysema.
    Intern Med. 2025;64:899-903.
    PubMed    
    Abstract available

  135. WANG J, Hu S, Xu Y, Wang T, et al
    Omega-6 polyunsaturated fatty acids and their metabolites: a potential targeted therapy for pulmonary hypertension.
    Respir Res. 2025;26:102.
    PubMed    
    Abstract available

  136. CARTON M, O'Driscoll D, Marsh B, Gaine S, et al
    Elevated right ventricular systolic pressure and outcomes after emergency hip surgery: a case control study.
    BMC Anesthesiol. 2025;25:128.
    PubMed    
    Abstract available

  137. RATHOD SN, Ropski P, Glowala J, Quinn CM, et al
    Overlap and correlation of reperfusion lung injury with postoperative pneumonia following pulmonary thromboendarterectomy: incidence, characteristics, and outcomes in chronic thromboembolic pulmonary hypertension.
    BMC Pulm Med. 2025;25:119.
    PubMed    
    Abstract available

  138. SU L, Wang X, Lin Y, Zhang Y, et al
    Exploring the Causal Relationship Between Gut Microbiota and Pulmonary Artery Hypertension: Insights From Mendelian Randomization.
    J Am Heart Assoc. 2025;14:e038150.
    PubMed    
    Abstract available

  139. MILANO G, Reinero M, Puyal J, Tozzi P, et al
    Inhibition of Sodium/Hydrogen Exchanger-1 in the Right Ventricle and Lung Dysfunction Induced by Experimental Pulmonary Arterial Hypertension in Rats.
    J Am Heart Assoc. 2025;14:e036859.
    PubMed    
    Abstract available

  140. SUN X, Yegambaram M, Lu Q, Garcia Flores AE, et al
    Mitochondrial fission produces a Warburg effect via the oxidative inhibition of prolyl hydroxylase domain-2.
    Redox Biol. 2025;81:103529.
    PubMed    
    Abstract available

  141. LI X, Hegarty K, Lin F, Chang JL, et al
    Endothelial Cpt1a Inhibits Neonatal Hyperoxia-Induced Pulmonary Vascular Remodeling by Repressing Endothelial-Mesenchymal Transition.
    Adv Sci (Weinh). 2025;12:e2415824.
    PubMed    
    Abstract available

  142. KWARTENG OWUSU S
    Sickle Lung Disease Long-Term Consequences and Prevention.
    Pediatr Pulmonol. 2025;60 Suppl 1:S102-S103.
    PubMed    
    Abstract available

  143. SELVADURAI Y, Le Fevre ER, Mervis J, Fitzgerald DA, et al
    Hereditary haemorrhagic telangiectasia: A primer for the paediatrician.
    Paediatr Respir Rev. 2025;53:30-34.
    PubMed    
    Abstract available

  144. COLEMAN RD, Cohen SP, Eghtesady P, Grady RM, et al
    Summary for Clinicians: Clinical Practice Guideline on Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy.
    Ann Am Thorac Soc. 2025 Mar 28. doi: 10.1513/AnnalsATS.202501.
    PubMed    
    Abstract available

  145. JAXA-KWIATKOWSKA K, Janus M, Graczyk MM, Szabatowska K, et al
    Hoarseness as a Rare Symptom of Idiopathic Pulmonary Arterial Hypertension Due to Ortner Syndrome: A Case Report.
    Am J Case Rep. 2025;26:e947011.
    PubMed    
    Abstract available

  146. GAUDIO A, Giordano N, Elhilali M, Schmidt S, et al
    Pulmonary Hypertension Detection from Heart Sound Analysis.
    IEEE Trans Biomed Eng. 2025;PP.
    PubMed    
    Abstract available

  147. MADONNA R, Montemaggi E
    Pulmonary hypertension and associated heart failure: New insights on emerging signalling pathways.
    Eur J Clin Invest. 2025 Mar 28:e70038. doi: 10.1111/eci.70038.
    PubMed    
    Abstract available

  148. FAROOQUI A, Alama M, Antoun I
    Draining Large Pericardial Effusion in a Pulmonary Hypertension Patient: Between a Rock and a Hard Place.
    Clin Case Rep. 2025;13:e70370.
    PubMed    
    Abstract available

  149. DRAGU R, Abramovici A, Abu Zeid K
    The Effect of Pulmonary Hypertension on Renal Function Dynamics in Left-Heart Failure Patients.
    Biomedicines. 2025;13:684.
    PubMed    
    Abstract available

  150. PENTIKAINEN M, Simonen P, Tuunanen H, Leskela P, et al
    Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH).
    JHLT Open. 2024;7:100191.
    PubMed    
    Abstract available

  151. KVITTING JE, Ravnestad H, Andersen R, Gjonnaess E, et al
    Chronic thromboembolic pulmonary hypertension.
    Tidsskr Nor Laegeforen. 2025;145.
    PubMed    
    Abstract available

  152. NICHOLSON MJ, Dhanani Z, Gayen S
    Pulmonary hypertension and lung transplantation waitlist outcomes for hypersensitivity pneumonitis.
    JHLT Open. 2024;6:100157.
    PubMed    
    Abstract available

  153. SWAMINATHAN AC, Meservey A, Parish A, Green CL, et al
    Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil.
    JHLT Open. 2024;6:100131.
    PubMed    
    Abstract available

  154. BAMBRICK M, Grafham G, Lajkosz K, Donahoe L, et al
    Computed tomography identifies sex-specific differences in surgical chronic thromboembolic pulmonary hypertension.
    JHLT Open. 2024;6:100130.
    PubMed    
    Abstract available

  155. EL-KERSH K, Bag R, Bhatt N, King C, et al
    Derivation of a simple risk calculator for predicting clinical worsening in patients with pulmonary hypertension due to interstitial lung disease.
    JHLT Open. 2025;7:100206.
    PubMed    
    Abstract available

  156. VON ALVENSLEBEN I, Graham BB, Balanza GA, Brockmann C, et al
    High Altitude May Protect Against the Early Development of Irreversible Pulmonary Hypertension in Patients With Congenital Heart Disease.
    Pulm Circ. 2025;15:e70049.
    PubMed    
    Abstract available

  157. IZHAKIAN S, Korlansky M, Rosengarten D, Bruckheimer E, et al
    Pulmonary artery stent thrombosis and symptomatic pulmonary hypertension following COVID-19 infection in Alagille patient: A case report.
    World J Clin Cases. 2025;13:96897.
    PubMed    
    Abstract available

  158. ADIB C, Modi S, Ramsammy V, Rosenheck J, et al
    Do not forget about the left ventricle after lung transplantation for pulmonary hypertension.
    JHLT Open. 2024;5:100112.
    PubMed    
    Abstract available

  159. ZHONG H, Yao L, An H, Fang L, et al
    MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2025 Mar 27. doi: 10.1161/ATVBAHA.124.322337.
    PubMed    
    Abstract available

  160. KATTIH Z, Kim HC, Aryal S, Nathan SD, et al
    Review of the Diagnosis and Management of Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH).
    J Clin Med. 2025;14:2029.
    PubMed    
    Abstract available

  161. YILDIRIM U, Taskin G, Baser MH, Tugmen B, et al
    Evaluation of Coronary Artery Luminal Diameters in Patients with Pulmonary Arterial Hypertension.
    Medicina (Kaunas). 2025;61:381.
    PubMed    
    Abstract available

  162. GAO X, Fan Y, Wang G, Xu J, et al
    Combined analysis of single-cell and bulk transcriptome sequencing data identifies critical glycolysis genes in idiopathic pulmonary arterial hypertension.
    J Transl Med. 2025;23:373.
    PubMed    
    Abstract available

  163. SCHAFER K
    Decorin and Right Ventricular Failure in Pulmonary Hypertension: A Proteoglycan Controlling TGF-beta Signaling in the Heart.
    JACC Basic Transl Sci. 2025;10:342-344.
    PubMed    


  164. AKAZAWA Y, Vaidyanathan S, Dewar MB, Yazaki K, et al
    Homeostatic Role of Decorin in Right Ventricular Pressure Overload and Pulmonary Hypertension Induced Remodeling.
    JACC Basic Transl Sci. 2025;10:323-341.
    PubMed    
    Abstract available

  165. ZHANG H, Lu X, Guo Z, Jiang X, et al
    Development of a clinically relevant rat model of chronic thromboembolic pulmonary hypertension by combining splenectomy with pulmonary thromboembolism.
    Thromb Res. 2025;249:109310.
    PubMed    
    Abstract available

  166. MATHAI SC, Mukherjee M
    When Incidence Leads to Precedence: A Call for Early Detection Protocols for Pulmonary Hypertension in Heart Failure and COPD.
    Ann Am Thorac Soc. 2025 Mar 25. doi: 10.1513/AnnalsATS.202503.
    PubMed    


  167. STEGER M, Canuet M, Martin G, Labani A, et al
    Pulmonary hypertension associated with COPD: a phenotype analysis.
    ERJ Open Res. 2025;11:00716-2024.
    PubMed    
    Abstract available

  168. WANG R, Wang J, Yu J, Li Z, et al
    Mfn2 regulates calcium homeostasis and suppresses PASMCs proliferation via interaction with IP3R3 to mitigate pulmonary arterial hypertension.
    J Transl Med. 2025;23:366.
    PubMed    
    Abstract available

  169. COPPI F, Pagnoni G, Campani C, Grossule F, et al
    Sjogren's syndrome and pulmonary hypertension: Exploring the intricate link with interstitial lung disease.
    Int J Cardiol. 2025;430:133185.
    PubMed    
    Abstract available

  170. THAKKAR B, Da Cunha T, Hagen R, Bath R, et al
    Pulmonary Hypertension and Downhill Varices: An Incidental Finding.
    Cureus. 2025;17:e79385.
    PubMed    
    Abstract available

  171. XIE W, Yu Y, Huang Q, Yan X, et al
    Epidemiology and management patterns of chronic thromboembolic pulmonary hypertension in China: a systematic literature review and meta-analysis.
    Chin Med J (Engl). 2025 Mar 24. doi: 10.1097/CM9.0000000000003580.
    PubMed    


  172. JAHNGIR MU, De Antonis C, Rabbani R, Ashiq A, et al
    Associations Between Type of Hemodialysis Access and Pulmonary Hypertension: A Single-Center Retrospective Cohort.
    Hemodial Int. 2025 Mar 23. doi: 10.1111/hdi.13231.
    PubMed    
    Abstract available

  173. GENECAND L, Wacker J, Guerreiro I, Lechartier B, et al
    Pulmonary hypertension associated with interstitial lung disease - a review on diagnosis and treatment with a focus on emerging therapies.
    Respiration. 2025 Mar 21:1-23. doi: 10.1159/000544800.
    PubMed    
    Abstract available

  174. ZHOU XZ, Guo RH, Yang YL, Wei JC, et al
    Application of factor D and other complement factors as systemic sclerosis-associated pulmonary hypertension: Comment of the article by Petrow et al.
    Semin Arthritis Rheum. 2025;72:152713.
    PubMed    


  175. JENY F, Valeyre D, Lower EE, Baughman RP, et al
    Advanced pulmonary sarcoidosis.
    J Autoimmun. 2025;152:103397.
    PubMed    
    Abstract available

  176. STRACQUALURSI M, Nemola G, Santangelo G, Moscardelli S, et al
    Monitoring SGLT2 inhibition effectiveness on pulmonary systolic pressure in heart failure with reduced ejection fraction.
    Int J Cardiol. 2025;428:133136.
    PubMed    
    Abstract available

  177. VAN KAN C, van Es J, Idrissi HE, Ruigrok D, et al
    Clinical and radiologic characteristics of chronic thromboembolic pulmonary hypertension patients without a history of acute venous thromboembolism.
    J Thromb Haemost. 2025 Mar 6:S1538-7836(25)00132.
    PubMed    
    Abstract available

  178. CHEN W, Chen J, Peng M, Luo J, et al
    Long-term survival of shunt closure in atrial septal defects with pulmonary arterial hypertension.
    Int J Cardiol. 2025;428:133094.
    PubMed    
    Abstract available

  179. SONG X, Xu Y, Li M, Guan X, et al
    SRSF4-Associated ca-circFOXP1 Regulates Hypoxia-Induced PASMC Proliferation by the Formation of R Loop With Host Gene.
    Arterioscler Thromb Vasc Biol. 2025;45:e118-e135.
    PubMed    
    Abstract available

  180. TATSUOKA Y, He Z, Lin HM, Notarianni AP, et al
    The role of right ventricular systolic pressure and ARISCAT score in perioperative pulmonary risk assessment.
    Braz J Anesthesiol. 2025;75:844597.
    PubMed    
    Abstract available

  181. PERISETLA N, Miranda C, Louis J, Omoike O, et al
    Inhaled epoprostenol via high-flow nasal cannula and intravenous treprostinil for management of severe pulmonary arterial hypertension during cesarean delivery with epidural anesthesia: a case report.
    Int J Obstet Anesth. 2025;61:104295.
    PubMed    
    Abstract available

  182. FAGHIHI-KASHANI S, Yoshida A, Bozan F, Zanframundo G, et al
    Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.
    Arthritis Rheumatol. 2025;77:477-489.
    PubMed    
    Abstract available

  183. LIU PY, Hsing SC, Tsai DJ, Lin C, et al
    A Deep-Learning-Enabled Electrocardiogram and Chest X-Ray for Detecting Pulmonary Arterial Hypertension.
    J Imaging Inform Med. 2025;38:747-756.
    PubMed    
    Abstract available

  184. BIRNHUBER A, Biasin V, Jain PP, Kwiatkowski G, et al
    Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness.
    Am J Physiol Lung Cell Mol Physiol. 2025;328:L413-L429.
    PubMed    
    Abstract available

  185. COOKSON MW, Gonzalez T, Bye EM, Seedorf G, et al
    Intraamniotic Vitamin D Preserves Lung Development and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia due to Intraamniotic sFlt-1.
    Am J Physiol Lung Cell Mol Physiol. 2025 Mar 24. doi: 10.1152/ajplung.00409.2024
    PubMed    
    Abstract available

  186. GILLMEYER KR, Johnson SW
    Pulmonary Hypertension Care Delivery in the U.S.: Is It Time to Get with the Guidelines?
    Am J Respir Crit Care Med. 2025 Feb 25. doi: 10.1164/rccm.202501-0107.
    PubMed    


  187. LECHUGA CG, Raza F, Colebank MJ, Korcarz CE, et al
    Characteristic Pulmonary Impedance With Exercise Detects Abnormal Pulmonary Vascular Response and Uncoupling in Pulmonary Hypertension Resulting From Heart Failure With Preserved Ejection Fraction.
    Chest. 2025 Feb 26:S0012-3692(25)00268-5. doi: 10.1016/j.chest.2025.
    PubMed    
    Abstract available

  188. CORDOVA FC, D'Alonzo G
    Phosphodiesterase Inhibitor Therapy in Pulmonary Hypertension-Associated COPD: Revisiting an Old Controversy With Renewed Interest.
    Chest. 2025;167:647-648.
    PubMed    


  189. ZHANG J, Gu X, Cheng TL, Qi YJ, et al
    ASH2L Deficiency in Smooth Muscle Drives Pulmonary Vascular Remodeling.
    Circ Res. 2025;136:719-734.
    PubMed    
    Abstract available

  190. DAI H, Lu X, Zhou X
    Letter by Dai et al Regarding Article, "Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction".
    Circulation. 2025;151:e686.
    PubMed    


  191. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2025;151:e763.
    PubMed    


  192. AUSTIN ED
    X-linked filaminopathy: another pulmonary hypertension syndrome.
    Eur Respir J. 2025;65:2500073.
    PubMed    


  193. KIKO T, Asano R, Yoshikawa Y, Endo H, et al
    Survival trends in patients with chronic thromboembolic pulmonary hypertension: An observational study.
    Eur Respir J. 2025 Mar 6:2402268. doi: 10.1183/13993003.02268-2024.
    PubMed    
    Abstract available

  194. LILEY J, Bunclark K, Newnham M, Cannon J, et al
    Development of an open-source tool for risk assessment in pulmonary endarterectomy.
    Eur Respir J. 2025;65:2401001.
    PubMed    
    Abstract available

  195. DUIJGHUISEN JJ, Hellemons ME, Horst MT
    Preoperative Femoral Extracorporeal Membrane Oxygenation Cannulation Using an Ilioinguinal Block for Lung Transplantation Recipients With Severe Pulmonary Hypertension.
    J Cardiothorac Vasc Anesth. 2025 Mar 4:S1053-0770(25)00206.
    PubMed    


  196. CHEN X, Xu L, Xue B
    Efficacy and safety of Treating Pulmonary Arterial Hypertension With Imatinib:A meta-analysis of randomized controlled trials.
    J Cardiovasc Pharmacol. 2025 Jan 2. doi: 10.1097/FJC.0000000000001665.
    PubMed    
    Abstract available

  197. WELLER S, Li S, Masha L
    Increases in donor/recipient predicted heart mass ratios do not result in large donor right ventricles.
    J Heart Lung Transplant. 2025;44:690-692.
    PubMed    
    Abstract available

  198. GOMBERG-MAITLAND M, Badesch DB, Gibbs JSR, Grunig E, et al
    Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR.
    J Heart Lung Transplant. 2025;44:609-624.
    PubMed    
    Abstract available

  199. JACQUET J, Marcos E, Lipskaia L, Gros V, et al
    [Senescence of the pulmonary endothelial cells: VEGF, a new target in pulmonary pathologies and aging].
    Rev Mal Respir. 2025;42:134-137.
    PubMed    
    Abstract available

  200. KIKO T, Tsuji A, Ueda J, Ohta-Ogo K, et al
    Vasodilator-induced selective pulmonary oedema in sarcoidosis-associated pulmonary hypertension with pulmonary venous stenosis.
    Thorax. 2025 Feb 27:thorax-2024-222190. doi: 10.1136/thorax-2024-222190.
    PubMed    


  201. LUIJTEN D, Rodenburg T, Bogaard HJ, Kianzad A, et al
    The value of vector ECG in predicting residual pulmonary hypertension in CTEPH patients after pulmonary endarterectomy.
    PLoS One. 2025;20:e0317826.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;